These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2097612)

  • 21. Principles for 3D/4D QSAR classification of drugs.
    Potemkin V; Grishina M
    Drug Discov Today; 2008 Nov; 13(21-22):952-9. PubMed ID: 18721896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme impairs allosterically drug binding to human serum albumin Sudlow's site I.
    Ascenzi P; Bocedi A; Notari S; Menegatti E; Fasano M
    Biochem Biophys Res Commun; 2005 Aug; 334(2):481-6. PubMed ID: 16004963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular dichroism in drug discovery and development: an abridged review.
    Bertucci C; Pistolozzi M; De Simone A
    Anal Bioanal Chem; 2010 Sep; 398(1):155-66. PubMed ID: 20658284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANN-QSAR model of drug-binding to human serum albumin.
    Deeb O; Hemmateenejad B
    Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 26. Expanding proteomics into the analysis of chiral drugs.
    Sui J; Zhang J; Ching CB; Chen WN
    Mol Biosyst; 2009 Jun; 5(6):603-8. PubMed ID: 19462017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput capillary electrophoresis frontal analysis method for the study of drug interactions with human serum albumin at near-physiological conditions.
    Martínez-Pla JJ; Martínez-Gómez MA; Martín-Biosca Y; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Electrophoresis; 2004 Oct; 25(18-19):3176-85. PubMed ID: 15472967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The classification of drugs and drug receptors in isolated tissues.
    Kenakin TP
    Pharmacol Rev; 1984 Sep; 36(3):165-222. PubMed ID: 6093156
    [No Abstract]   [Full Text] [Related]  

  • 31. Types of stereoselectivity in drug metabolism: a heuristic approach.
    Testa B
    Drug Metab Rev; 2015 May; 47(2):239-51. PubMed ID: 25410915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ion channels as pharmacologic receptors: the chirality of drug interactions.
    Triggle DJ
    Chirality; 1996; 8(1):35-8. PubMed ID: 8845280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Receptors; from idea to reality].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of site-specific binding to plasma albumin in drug availability to brain.
    Mandula H; Parepally JM; Feng R; Smith QR
    J Pharmacol Exp Ther; 2006 May; 317(2):667-75. PubMed ID: 16410405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions.
    Testa B
    Chirality; 1989; 1(1):7-9. PubMed ID: 2701849
    [No Abstract]   [Full Text] [Related]  

  • 37. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of drug binding sites on rat and human serum albumins using immobilized-protein stationary phases as a tool for the selection of suitable animal models in pharmacological studies.
    Massolini G; De Lorenzi E; Ponci MC; Caccialanza G
    Boll Chim Farm; 1996 Jun; 135(6):382-6. PubMed ID: 8942065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A microcomputer program for the analysis of the drug-receptor bond using radioligands].
    García AJ; Ríus F; López DR; Martos F; de la Cruz JP; Gómez JA; Sánchez de la Cuesta F
    Arch Farmacol Toxicol; 1986 Apr; 12(1):71-82. PubMed ID: 3755582
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of glycosylation on the drug binding of human serum albumin.
    Koizumi K; Ikeda C; Ito M; Suzuki J; Kinoshita T; Yasukawa K; Hanai T
    Biomed Chromatogr; 1998; 12(4):203-10. PubMed ID: 9667024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.